710281005: Insulin degludec (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\...

\Pancreatic hormone\Insulin\Insulin degludec (substance)

\Polypeptide hormone\Insulin\Insulin degludec (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\...

\Pancreatic hormone\Insulin\Insulin degludec (substance)

\Polypeptide hormone\Insulin\Insulin degludec (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\...

\Polypeptide\Polypeptide hormone\Insulin\Insulin degludec (substance)

\Pancreatic hormone\Insulin\Insulin degludec (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\...

\Polypeptide\Polypeptide hormone\Insulin\Insulin degludec (substance)

\Pancreatic hormone\Insulin\Insulin degludec (substance)

\Biological substance\Polypeptide\Polypeptide hormone\Insulin\Insulin degludec (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3044332010 Insulin degludec (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3044426018 Insulin degludec en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

59911000195115 insulina degludec it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

817941000172110 insuline dégludec fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

75571000195118 Insulin degludec de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Insulin degludec (substance)	Is a	Ultra long-acting insulin	false	Inferred relationship	Some
Insulin degludec (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Pancreatic hormone (disposition)	true	Inferred relationship	Some
Insulin degludec (substance)	Is a	Insulin	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing insulin aspart and insulin degludec (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	2
Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	2
Product containing insulin degludec (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	1
Product containing insulin degludec in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	1
Product containing insulin degludec and liraglutide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	2
Product containing insulin degludec and liraglutide in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	2
Insulin degludec only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	1
Insulin degludec and liraglutide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	2
Product containing only insulin aspart and insulin degludec (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	2
Insulin aspart and insulin degludec only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	2
Insulin degludec and liraglutide only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	2
Product containing only insulin degludec in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Insulin degludec (substance)	Inferred relationship	Some	1
Insulin degludec 100 unit/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Insulin degludec (substance)	Inferred relationship	Some	1
Insulin degludec 100 unit/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Insulin degludec (substance)	Inferred relationship	Some	1
Insulin degludec 200 unit/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Insulin degludec (substance)	Inferred relationship	Some	1
Insulin degludec 200 unit/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Insulin degludec (substance)	Inferred relationship	Some	1
Product containing precisely insulin degludec 100 unit/1 milliliter and liraglutide 3.6 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Insulin degludec (substance)	Inferred relationship	Some	2
Product containing precisely insulin degludec 100 unit/1 milliliter and liraglutide 3.6 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Insulin degludec (substance)	Inferred relationship	Some	2

This concept is not in any reference sets